Skip to Main Content

Anna Vinitsky, MD, MS

Associate Member, St. Jude Faculty

On this page:

Contact Information

Anna Vinitsky, MD, MS

Neuro-Oncology

MS 260, Room C6068

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN 3810-3678

Education

MD - Minsk State Medical Institute, Minsk, Belarus MS - Medical College of Wisconsin, Milwaukee, Wisconsin Residency (Pediatrics) - Marshfield Clinic-Saint Joseph’s Children’s Hospital of Marshfield, Marshfield, Wisconsin Fellowship (Pediatric Hematology/Oncology) – Medical College of Wisconsin, Milwaukee, Wisconsin Fellowship (Pediatric Neuro-Oncology) – St. Jude Children’s Research Hospital

Research Interests

  • Pediatric neuro-oncology
  • Optimization of the delivery of medical care
  • Process improvement and implementation of "Lean Methodology" to improve clinical efficiency 

Clinical Trials

Recruiting
SJ901: Study of Mirdametinib as a Treatment for Children, Adolescents and Young Adults with Low-Grade Glioma

Study goal:

The main goal of this study is to test the experimental drug mirdametinib in hopes of finding a treatment that may be effective against low-grade glioma brain tumors in children, adolescents and young adults.

Age:

At least 2 years old and younger than 25 years old.

PBTC49: Phase 1 Trial of Savolitinib in Recurrent, Progressive or Refractory Medulloblastoma, High-Grade Glioma, or Diffuse Intrinsic Pontine Glioma

Study goal:

 To see if savolitinib is safe and tolerable in children with brain tumors

Age:

Between 5 years old and 21 years old

Recruiting
PBTC48: Optune for High-Grade Glioma, Ependymoma, or Diffuse Intrinsic Pontine Glioma

Study goal:

To see how well children with high-grade glioma and ependymoma can use the Optune device and what side effects it may cause; and to see if Optune and radiation therapy are safe and effective for diffuse intrinsic pontine glioma. 

Age:

3-21 years

Dr. Vinitsky in Progress

St. Jude Publications